Literature DB >> 30258472

Blepharospasm in Japan: A Clinical Observational Study From a Large Referral Hospital in Tokyo.

M Wakakura1, A Yamagami1, M Iwasa1.   

Abstract

Focal dystonia is regarded as a characteristic feature of blepharospasm. However, patients do not always present with motor symptoms. To clarify the clinical features of blepharospasm in Japan, we conducted a retrospective observational study involving a large population of patients from a single institution. Common symptoms included difficulty opening the eyes, photophobia, and ocular pain/irritation. Initial symptoms often occurred following the long-term use of psychotropics such as etizoram, benzodiazepines, and zolpidem (32% of patients). Our findings demonstrated that the clinical presentation of blepharospasm is heterogenous, and that understanding regarding sensory-dominant forms of the disease may be poor among practitioners in Japan.

Entities:  

Keywords:  Blepharospasm; benzodiazepines; focal dystonia; psychotropics; sensory-motor disintegration

Year:  2018        PMID: 30258472      PMCID: PMC6152494          DOI: 10.1080/01658107.2017.1409770

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  26 in total

Review 1.  The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors.

Authors:  Amanda C Fitzgerald; Brittany T Wright; Scott A Heldt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-22       Impact factor: 4.530

Review 2.  Meige's syndrome: History, epidemiology, clinical features, pathogenesis and treatment.

Authors:  Sanjay Pandey; Soumya Sharma
Journal:  J Neurol Sci       Date:  2016-11-23       Impact factor: 3.181

Review 3.  Shedding light on photophobia.

Authors:  Kathleen B Digre; K C Brennan
Journal:  J Neuroophthalmol       Date:  2012-03       Impact factor: 3.042

4.  A novel mechanism for benign essential blepharospasm.

Authors:  J D McCann; M Gauthier; R Morschbacher; R A Goldberg; R L Anderson; P G Fine; K B Digre
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1999-11       Impact factor: 1.746

5.  Photophobia in essential blepharospasm--a positron emission tomographic study.

Authors:  Hirofumi Emoto; Yukihisa Suzuki; Masato Wakakura; Chiharu Horie; Motohiro Kiyosawa; Manabu Mochizuki; Keiichi Kawasaki; Keiichi Oda; Kiichi Ishiwata; Kenji Ishii
Journal:  Mov Disord       Date:  2010-03-15       Impact factor: 10.338

6.  Psychological aspects of essential blepharospasm.

Authors:  E L Diamond; J D Trobe; C D Belar
Journal:  J Nerv Ment Dis       Date:  1984-12       Impact factor: 2.254

7.  Resting state fMRI observations of baseline brain functional activities and connectivities in primary blepharospasm.

Authors:  Ming-Fei Ni; Xiao-Feng Huang; Yan-Wei Miao; Zhan-Hua Liang
Journal:  Neurosci Lett       Date:  2017-09-08       Impact factor: 3.046

8.  Twelve cases of drug-induced blepharospasm improved within 2 months of psychotropic cessation.

Authors:  Yuko Emoto; Hirofumi Emoto; Eriko Oishi; Syunichi Hikita; Masato Wakakura
Journal:  Drug Healthc Patient Saf       Date:  2011-06-03

9.  A Dynamic Circuit Hypothesis for the Pathogenesis of Blepharospasm.

Authors:  David A Peterson; Terrence J Sejnowski
Journal:  Front Comput Neurosci       Date:  2017-03-07       Impact factor: 2.380

Review 10.  Blepharospasm: Update on Epidemiology, Clinical Aspects, and Pathophysiology.

Authors:  Josep Valls-Sole; Giovanni Defazio
Journal:  Front Neurol       Date:  2016-03-31       Impact factor: 4.003

View more
  4 in total

1.  Treatment of blepharospasm and Meige's syndrome with abo- and onabotulinumtoxinA: long-term safety and efficacy in daily clinical practice.

Authors:  Angela Jochim; Tobias Meindl; Christoph Huber; Tobias Mantel; Silke Zwirner; Florian Castrop; Bernhard Haslinger
Journal:  J Neurol       Date:  2019-10-19       Impact factor: 4.849

2.  Differences in detected safety signals between benzodiazepines and non-benzodiazepine hypnotics: pharmacovigilance study using a spontaneous reporting system.

Authors:  Manabu Toyoshima; Yoshihiro Noguchi; Manami Otsubo; Tomoya Tachi; Hitomi Teramachi
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

3.  Clinical Features and Evolution of Blepharospasm: A Multicenter International Cohort and Systematic Literature Review.

Authors:  Laura M Scorr; Hyun Joo Cho; Gamze Kilic-Berkmen; J Lucas McKay; Mark Hallett; Christine Klein; Tobias Baumer; Brian D Berman; Jeanne S Feuerstein; Joel S Perlmutter; Alfredo Berardelli; Gina Ferrazzano; Aparna Wagle-Shukla; Irene A Malaty; Joseph Jankovic; Steven T Bellows; Richard L Barbano; Marie Vidailhet; Emmanuel Roze; Cecilia Bonnet; Abhimanyu Mahajan; Mark S LeDoux; Victor S C Fung; Florence C F Chang; Giovanni Defazio; Tomaso Ercoli; Stewart Factor; Ted Wojno; H A Jinnah
Journal:  Dystonia       Date:  2022-05-16

4.  Subjective assessment of effectiveness, quality of life, and psychological status of patients receiving botulinum toxin therapy for hemifacial spasm, blepharospasm, or cervical dystonia.

Authors:  Tetsuharu Kako; Kazuya Nokura; Hiroshi Kaneko; Hideo Izawa
Journal:  Fujita Med J       Date:  2020-07-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.